Nebivolol Teva

Nebivolol, the active ingredient in Nebivolol Teva, is a beta blocker presented as an oral tablet for oral use. It selectively blocks β1‑adrenergic receptors and promotes nitric‑oxide mediated vasodilation, helping to lower elevated blood pressure in adult patients with hypertension.\n\nGNH India supplies Nebivolol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is indicated for conditions within the cardiovascular system where blood pressure reduction is required.\n\n- Hypertension: lowers systolic and diastolic blood pressure, improving cardiovascular risk profile.\n- Essential hypertension: provides consistent blood pressure control in patients with primary high blood pressure.\n- High blood pressure in the elderly: offers effective management with a favorable tolerability profile.

Nebivolol may cause a range of adverse reactions, which are categorized by frequency and severity.\n\nCommon Side Effects:\n- Headache: mild to moderate intensity.\n- Dizziness: especially upon standing.\n- Fatigue: general tiredness.\n- Bradycardia: reduced heart rate.\n- Nausea: occasional stomach upset.\n- Nasal congestion: mild blockage.\n\nSerious or Rare Side Effects:\n- Severe bradycardia: markedly low heart rate requiring medical attention.\n- Heart block: conduction disturbances.\n- Acute hypotension: sudden drop in blood pressure.\n- Allergic reactions: rash, itching, swelling,